Evidence map›Paper›PMID 31256292›Full record

ArticleInflammation2019

Nrf2 Activator RTA-408 Protects Against Ozone-Induced Acute Asthma Exacerbation by Suppressing ROS and γδT17 Cells.

Jing-Hong Zhang, Xia Yang, Yi-Ping Chen, Jian-Feng Zhang, Chao-Qian Li

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. In vivo and in vitro Models of PM2.5 Induced COPD: Focus on the Role of RTA-408.International journal of chronic obstructive pulmonary disease · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jing-Hong ZhangDepartment of Emergency, The First Affiliated Hospital of Guangxi Medical University, the Guangxi Talent Highland for Emergency and Rescue Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China.
Xia YangDepartment of Emergency, The First Affiliated Hospital of Guangxi Medical University, the Guangxi Talent Highland for Emergency and Rescue Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China.
Yi-Ping ChenDepartment of Emergency, The First Affiliated Hospital of Guangxi Medical University, the Guangxi Talent Highland for Emergency and Rescue Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China.
Jian-Feng ZhangDepartment of Emergency, The First Affiliated Hospital of Guangxi Medical University, the Guangxi Talent Highland for Emergency and Rescue Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China. zhangjianfeng930@163.com.
Chao-Qian LiDepartment of Emergency, The First Affiliated Hospital of Guangxi Medical University, the Guangxi Talent Highland for Emergency and Rescue Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China. leechaoqian@163.com.
First Affiliated Hospital of GuangXi Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ozone is a strong oxidant in air pollution that exacerbates respiratory disorders and is a major risk factor for acute asthma exacerbation. Ozone can induce reactive oxygen species (ROS) and airway neutrophilic inflammation. In addition, γδT17 cells contribute to IL-17A production upon ozone challenge, resulting in neutrophilic inflammation. It is known, however, that Nrf2 can ameliorate oxidative stress. We therefore investigated whether RTA-408, an Nrf2 activator, can attenuate airway inflammation and inhibit ROS production and whether this effect involves γδT17 cells. Balb/c mice were sensitized/challenged with ovalbumin (OVA) and followed by ozone exposure. We investigated the effect of Nrf2 activator RTA-408 on airway hyperresponsiveness, neutrophilic airway inflammation, cytokine/chemokine production, and OVA-specific IgE level in a mouse model of O3 induced asthma exacerbation. Furthermore, malondialdehyde (MDA) and glutathione (GSH) levels in lung and intracellular ROS were measured. IL-17

Indexed as

AnimalsAsthmaCell LineInflammationInterleukin-17Lymphocyte CountMiceMice, Inbred BALB CNF-E2-Related Factor 2OzoneProtective AgentsReactive Oxygen SpeciesTh17 CellsTriterpenesInterleukin-17NF-E2-Related Factor 2omaveloxoloneOzoneProtective AgentsReactive Oxygen SpeciesTriterpenesasthma exacerbationNrf2oxidative stressozoneγδT17 cell

Identifiers

PMID31256292
OpenAlexW2954009327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.